Allscripts Reports Third Quarter 20...(56191 53048 55500 50081 Weigh...),Health

Weighted average shares of common

stock outstanding used in

computing diluted net income per

share (c) 65,225 55,676 64,541 52,572

(a) Includes stock-based compensation of $247 and $0 for the three

months ended September 30, 2007 and 2006, respectively and $432 and

$0 for the nine months ended September 30, 2007 and 2006,

respectively.

(b) Includes stock-based compensation of $1,262 and $617 for the three

months ended September 30, 2007 and 2006, respectively and $2,358

and $1,440 for the nine months ended September 30, 2007 and 2006,

respectively.

(c) Weighted average diluted shares for the three and nine months ended

September 30, 2007 include 7,329 common shares related to the

Company's 3.5% Senior Convertible Notes. Such shares were

antidilutive for the three and nine months ended September 30, 2006.

Interest expense, net of tax, totaling $521 has been added back to

net income for the net income per diluted share calculation for the

three and nine months ended September 30, 2007.

Allscripts Healthcare Solutions, Inc.

Reconciliation of Non-GAAP Adjusted Earnings and Non-GAAP

Adjusted Earnings Per Share

(amounts in thousands, except per-share amounts)

(Unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

Net Income $4,124 $3,262 $14,619 $7,412

Stock compensation expense (tax

effected at 40% for 2007 and

38% for 2006)
'/>"/>